Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-02-06 @ 6:49 PM
Study NCT ID:
NCT03750669
Status:
COMPLETED
Last Update Posted:
2025-05-13
First Post:
2018-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-17
First Submit QC Date:
None
Study First Post Date:
2018-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-07
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL